Literature DB >> 27276984

Improved prediction of antibody VL-VH orientation.

Nicholas A Marze1, Sergey Lyskov1, Jeffrey J Gray1,2,3.   

Abstract

Antibodies are important immune molecules with high commercial value and therapeutic interest because of their ability to bind diverse antigens. Computational prediction of antibody structure can quickly reveal valuable information about the nature of these antigen-binding interactions, but only if the models are of sufficient quality. To achieve high model quality during complementarity-determining region (CDR) structural prediction, one must account for the VL-VH orientation. We developed a novel four-metric VL-VH orientation coordinate frame. Additionally, we extended the CDR grafting protocol in RosettaAntibody with a new method that diversifies VL-VH orientation by using 10 VL-VH orientation templates rather than a single one. We tested the multiple-template grafting protocol on two datasets of known antibody crystal structures. During the template-grafting phase, the new protocol improved the fraction of accurate VL-VH orientation predictions from only 26% (12/46) to 72% (33/46) of targets. After the full RosettaAntibody protocol, including CDR H3 remodeling and VL-VH re-orientation, the new protocol produced more candidate structures with accurate VL-VH orientation than the standard protocol in 43/46 targets (93%). The improved ability to predict VL-VH orientation will bolster predictions of other parts of the paratope, including the conformation of CDR H3, a grand challenge of antibody homology modeling.
© The Author 2016. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com.

Keywords:  antibody modeling; antibody structure; computational structure prediction; domain orientation

Mesh:

Substances:

Year:  2016        PMID: 27276984      PMCID: PMC5036862          DOI: 10.1093/protein/gzw013

Source DB:  PubMed          Journal:  Protein Eng Des Sel        ISSN: 1741-0126            Impact factor:   1.650


  17 in total

1.  The Protein Data Bank.

Authors:  H M Berman; J Westbrook; Z Feng; G Gilliland; T N Bhat; H Weissig; I N Shindyalov; P E Bourne
Journal:  Nucleic Acids Res       Date:  2000-01-01       Impact factor: 16.971

2.  Analysis and prediction of VH/VL packing in antibodies.

Authors:  K R Abhinandan; Andrew C R Martin
Journal:  Protein Eng Des Sel       Date:  2010-06-30       Impact factor: 1.650

3.  A new clustering of antibody CDR loop conformations.

Authors:  Benjamin North; Andreas Lehmann; Roland L Dunbrack
Journal:  J Mol Biol       Date:  2010-10-28       Impact factor: 5.469

4.  Prediction of VH-VL domain orientation for antibody variable domain modeling.

Authors:  Alexander Bujotzek; James Dunbar; Florian Lipsmeier; Wolfgang Schäfer; Iris Antes; Charlotte M Deane; Guy Georges
Journal:  Proteins       Date:  2015-02-05

5.  A systematic comparison of free and bound antibodies reveals binding-related conformational changes.

Authors:  Inbal Sela-Culang; Shahar Alon; Yanay Ofran
Journal:  J Immunol       Date:  2012-10-12       Impact factor: 5.422

6.  Second antibody modeling assessment (AMA-II).

Authors:  Juan C Almagro; Alexey Teplyakov; Jinquan Luo; Raymond W Sweet; Sreekumar Kodangattil; Francisco Hernandez-Guzman; Gary L Gilliland
Journal:  Proteins       Date:  2014-04-26

7.  Reshaping antibody diversity.

Authors:  Feng Wang; Damian C Ekiert; Insha Ahmad; Wenli Yu; Yong Zhang; Omar Bazirgan; Ali Torkamani; Terje Raudsepp; Waithaka Mwangi; Michael F Criscitiello; Ian A Wilson; Peter G Schultz; Vaughn V Smider
Journal:  Cell       Date:  2013-06-06       Impact factor: 41.582

8.  The origin of CDR H3 structural diversity.

Authors:  Brian D Weitzner; Roland L Dunbrack; Jeffrey J Gray
Journal:  Structure       Date:  2015-01-08       Impact factor: 5.006

9.  PyIgClassify: a database of antibody CDR structural classifications.

Authors:  Jared Adolf-Bryfogle; Qifang Xu; Benjamin North; Andreas Lehmann; Roland L Dunbrack
Journal:  Nucleic Acids Res       Date:  2014-11-11       Impact factor: 19.160

10.  Serverification of molecular modeling applications: the Rosetta Online Server that Includes Everyone (ROSIE).

Authors:  Sergey Lyskov; Fang-Chieh Chou; Shane Ó Conchúir; Bryan S Der; Kevin Drew; Daisuke Kuroda; Jianqing Xu; Brian D Weitzner; P Douglas Renfrew; Parin Sripakdeevong; Benjamin Borgo; James J Havranek; Brian Kuhlman; Tanja Kortemme; Richard Bonneau; Jeffrey J Gray; Rhiju Das
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

View more
  23 in total

1.  Accurate Structure Prediction of CDR H3 Loops Enabled by a Novel Structure-Based C-Terminal Constraint.

Authors:  Brian D Weitzner; Jeffrey J Gray
Journal:  J Immunol       Date:  2016-11-21       Impact factor: 5.422

2.  Web-accessible molecular modeling with Rosetta: The Rosetta Online Server that Includes Everyone (ROSIE).

Authors:  Rocco Moretti; Sergey Lyskov; Rhiju Das; Jens Meiler; Jeffrey J Gray
Journal:  Protein Sci       Date:  2017-10-27       Impact factor: 6.725

3.  High-resolution mapping of the polyclonal immune response to the human platelet alloantigen HPA-1a (PlA1).

Authors:  Huiying Zhi; Maria Therese Ahlen; Aye Myat Myat Thinn; Hartmut Weiler; Brian R Curtis; Bjørn Skogen; Jieqing Zhu; Peter J Newman
Journal:  Blood Adv       Date:  2018-11-13

4.  Modeling and docking of antibody structures with Rosetta.

Authors:  Brian D Weitzner; Jeliazko R Jeliazkov; Sergey Lyskov; Nicholas Marze; Daisuke Kuroda; Rahel Frick; Jared Adolf-Bryfogle; Naireeta Biswas; Roland L Dunbrack; Jeffrey J Gray
Journal:  Nat Protoc       Date:  2017-01-26       Impact factor: 13.491

5.  A high-affinity human TCR-like antibody detects celiac disease gluten peptide-MHC complexes and inhibits T cell activation.

Authors:  Rahel Frick; Lene S Høydahl; Jan Petersen; M Fleur du Pré; Shraddha Kumari; Grete Berntsen; Alisa E Dewan; Jeliazko R Jeliazkov; Kristin S Gunnarsen; Terje Frigstad; Erik S Vik; Carmen Llerena; Knut E A Lundin; Sheraz Yaqub; Jørgen Jahnsen; Jeffrey J Gray; Jamie Rossjohn; Ludvig M Sollid; Inger Sandlie; Geir Åge Løset
Journal:  Sci Immunol       Date:  2021-08-20

6.  Plasma Cells Are the Most Abundant Gluten Peptide MHC-expressing Cells in Inflamed Intestinal Tissues From Patients With Celiac Disease.

Authors:  Lene Støkken Høydahl; Lisa Richter; Rahel Frick; Omri Snir; Kristin Støen Gunnarsen; Ole J B Landsverk; Rasmus Iversen; Jeliazko R Jeliazkov; Jeffrey J Gray; Elin Bergseng; Stian Foss; Shuo-Wang Qiao; Knut E A Lundin; Jørgen Jahnsen; Frode L Jahnsen; Inger Sandlie; Ludvig M Sollid; Geir Åge Løset
Journal:  Gastroenterology       Date:  2018-12-26       Impact factor: 22.682

7.  Modeling Immunity with Rosetta: Methods for Antibody and Antigen Design.

Authors:  Clara T Schoeder; Samuel Schmitz; Jared Adolf-Bryfogle; Alexander M Sevy; Jessica A Finn; Marion F Sauer; Nina G Bozhanova; Benjamin K Mueller; Amandeep K Sangha; Jaume Bonet; Jonathan H Sheehan; Georg Kuenze; Brennica Marlow; Shannon T Smith; Hope Woods; Brian J Bender; Cristina E Martina; Diego Del Alamo; Pranav Kodali; Alican Gulsevin; William R Schief; Bruno E Correia; James E Crowe; Jens Meiler; Rocco Moretti
Journal:  Biochemistry       Date:  2021-03-11       Impact factor: 3.162

Review 8.  How B-Cell Receptor Repertoire Sequencing Can Be Enriched with Structural Antibody Data.

Authors:  Aleksandr Kovaltsuk; Konrad Krawczyk; Jacob D Galson; Dominic F Kelly; Charlotte M Deane; Johannes Trück
Journal:  Front Immunol       Date:  2017-12-08       Impact factor: 7.561

Review 9.  Macromolecular modeling and design in Rosetta: recent methods and frameworks.

Authors:  Julia Koehler Leman; Brian D Weitzner; Steven M Lewis; Jared Adolf-Bryfogle; Nawsad Alam; Rebecca F Alford; Melanie Aprahamian; David Baker; Kyle A Barlow; Patrick Barth; Benjamin Basanta; Brian J Bender; Kristin Blacklock; Jaume Bonet; Scott E Boyken; Phil Bradley; Chris Bystroff; Patrick Conway; Seth Cooper; Bruno E Correia; Brian Coventry; Rhiju Das; René M De Jong; Frank DiMaio; Lorna Dsilva; Roland Dunbrack; Alexander S Ford; Brandon Frenz; Darwin Y Fu; Caleb Geniesse; Lukasz Goldschmidt; Ragul Gowthaman; Jeffrey J Gray; Dominik Gront; Sharon Guffy; Scott Horowitz; Po-Ssu Huang; Thomas Huber; Tim M Jacobs; Jeliazko R Jeliazkov; David K Johnson; Kalli Kappel; John Karanicolas; Hamed Khakzad; Karen R Khar; Sagar D Khare; Firas Khatib; Alisa Khramushin; Indigo C King; Robert Kleffner; Brian Koepnick; Tanja Kortemme; Georg Kuenze; Brian Kuhlman; Daisuke Kuroda; Jason W Labonte; Jason K Lai; Gideon Lapidoth; Andrew Leaver-Fay; Steffen Lindert; Thomas Linsky; Nir London; Joseph H Lubin; Sergey Lyskov; Jack Maguire; Lars Malmström; Enrique Marcos; Orly Marcu; Nicholas A Marze; Jens Meiler; Rocco Moretti; Vikram Khipple Mulligan; Santrupti Nerli; Christoffer Norn; Shane Ó'Conchúir; Noah Ollikainen; Sergey Ovchinnikov; Michael S Pacella; Xingjie Pan; Hahnbeom Park; Ryan E Pavlovicz; Manasi Pethe; Brian G Pierce; Kala Bharath Pilla; Barak Raveh; P Douglas Renfrew; Shourya S Roy Burman; Aliza Rubenstein; Marion F Sauer; Andreas Scheck; William Schief; Ora Schueler-Furman; Yuval Sedan; Alexander M Sevy; Nikolaos G Sgourakis; Lei Shi; Justin B Siegel; Daniel-Adriano Silva; Shannon Smith; Yifan Song; Amelie Stein; Maria Szegedy; Frank D Teets; Summer B Thyme; Ray Yu-Ruei Wang; Andrew Watkins; Lior Zimmerman; Richard Bonneau
Journal:  Nat Methods       Date:  2020-06-01       Impact factor: 28.547

10.  Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture.

Authors:  Jerome E Tanner; Jing Hu; Caroline Alfieri
Journal:  Cancers (Basel)       Date:  2018-04-09       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.